Straumann: Mid-term goals with high growth rates convince investors!
Reading Time: 2 minutes
The Straumann Group is a leader in dental implants and aesthetic dentistry. The company's core business traditionally consists of implantology, where Straumann holds a dominating role with an estimated global market share of around 35%. The product range includes premium implants, biomaterials for bone and tissue regeneration, and prosthetic components. Additionally, the company offers innovative solutions in orthodontics, such as aligner systems, and with its Digital Solutions, it is paving the way for the future of dentistry. With premium brands...
Read this article now with a free account.
Your benefits:
- Every month, you can read 5 articles from the premium section for free.
- Monthly 2 trial issues of the Trader newspaper for free.
- Create a personal watchlist with an overview of news about your stock.
